EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Potential role of the ocular surface microbiome in dry eye: microbial interactions and symptom alleviation

Joon-Young Park, Chang Ki Yoon, Jin-Jae Lee, Young Joo Shin iD, Bong-Soo Kim iD

mSystems · 21.04.2026 · 11 (4)

DOI: 10.1128/msystems.00104-26 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift mSystems, erschienen am 21.04.2026. Verfasst von Joon-Young Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Multidisciplinary Genome Institute, Hallym University, Chuncheon, Gangwon-do, Republic of Korea. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Eye, Microbial Interactions, Microbiota. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, Korea National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye is a prevalent ocular disorder characterized by tear film instability, inflammation, and ocular discomfort. Although the ocular surface (OS) microbiome contributes to immune regulation and pathogen defense, its role in dry eye pathophysiology remains unclear. Therefore, the present study aimed to characterize alterations in the OS microbiome of patients with dry eye undergoing cyclosporin A or NewHyalUni treatment and to identify their potential roles related to clinical improvement. Patients with dry eye were treated with either cyclosporin A and NewHyalUni drop combination or NewHyalUni alone. OS samples were collected before and after treatment, and the microbiome was analyzed by whole metagenome sequencing. Potential contaminants were removed before downstream analysis to account for the low-biomass nature of OS samples. Clinical evaluations included symptom scores and the assessment of meibomian gland dysfunction (MGD). No significant differences in the overall microbial composition were observed between the treatment groups. Nevertheless, both groups demonstrated symptomatic improvement. OS microbiome alterations were strongly correlated with improvements in MGD scores. Moreover, microbial interactions were found to shift following treatment. Key species ( Staphylococcus epidermidis , Staphylococcus pseudintermedius , Streptomyces lividans, and Edwardsiella tarda ) were identified as potential mediators of MGD score improvement by modulating microbiome functions and suppressing inflammation-associated species. Although distinct treatment regimens did not lead to divergent microbiome profiles, symptomatic improvement was associated with alterations in a specific microbiome. These findings highlight the OS microbiome’s potential role in dry eye and support the development of microbiome-based therapeutic strategies. IMPORTANCE Dry eye is a common ocular disorder with complex pathophysiology that extends beyond tear deficiency and inflammation. Despite growing evidence of host-microbiome interactions at mucosal surfaces, the contribution of the ocular surface (OS) microbiome to dry eye remains poorly understood. Our findings in this study reveal that shifts in specific taxa and ecological interactions correlate with improvements in meibomian gland function and dry eye symptoms, even in the absence of major changes in overall microbiota. By identifying microbial signatures potentially linked to clinical improvement, we provide systems-level insight into the role of low-biomass microbiomes in ocular health. This work expands the current understanding of microbiome-host dynamics in non-gut environments and supports future development of microbiome-informed therapeutic strategies. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT06936462 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesEyeMicrobial InteractionsMicrobiotaAgedFemaleHumansMaleMiddle AgedBacteriaCyclosporineMeibomian Gland DysfunctionMeibomian GlandsTears

Stichwörter der Autor:innen

dry eyemeibomian gland dysfunctionmicrobiome modulationocular surface microbiome

Substanzen

Cyclosporine

Autor:innen und Institutionen

  • Department of Life Science, Multidisciplinary Genome Institute, Hallym University, Chuncheon, Gangwon-do, Republic of Korea.
  • Department of Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Ophthalmology, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Hallym BioEyeTech Research Center, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Department of Nutritional Science and Food Management, Ewha Womans University, Seoul, Republic of Korea.
  • Global Food and Nutrition Research Institute, Ewha Womans University, Seoul, Republic of Korea.

ORCID-Profile: Young Joo Shin, Bong-Soo Kim

Förderung

  • Ministry of Science and ICT, South Korea
  • Korea National Institute of Health

Zitieren

APA

Park, J. Y., Yoon, C. K., Lee, J. J., Shin, Y. J., & Kim, B. S. (2026). Potential role of the ocular surface microbiome in dry eye: microbial interactions and symptom alleviation. mSystems, 11(4). https://doi.org/10.1128/msystems.00104-26

Vancouver

Park JY, Yoon CK, Lee JJ, Shin YJ, Kim BS. Potential role of the ocular surface microbiome in dry eye: microbial interactions and symptom alleviation. mSystems. 2026;11(4). doi:10.1128/msystems.00104-26

BibTeX
@article{Park2026,
  author = {Park, Joon-Young and Yoon, Chang Ki and Lee, Jin-Jae and Shin, Young Joo and Kim, Bong-Soo},
  title = {Potential role of the ocular surface microbiome in dry eye: microbial interactions and symptom alleviation},
  journal = {mSystems},
  year = {2026},
  volume = {11},
  number = {4},
  doi = {10.1128/msystems.00104-26}
}
Kostenlos starten →